CSL has priced US$1.5 billion of corporate bonds in the United States, turning to offshore debt markets to refinance its ...

An experimental treatment being developed by Syntara improved movement in people at high risk of developing Parkinson's disease, and the benefit held for three months after treatment stopped, ...

Seven leading Chinese medical societies have jointly published an expert consensus naming Technegas the preferred ventilation agent for lung imaging in pulmonary embolism, handing the Sydney ...

Perth-based company PYC Therapeutics will take early human data on its polycystic kidney disease drug to the American Society of Nephrology conference in Denver on 22 October.

Australians living with wet age-related macular degeneration may soon be able to replace regular eye injections with a ...

Latest News; Young NZ cancer patients to get funded medicines no ma ...

Hayley Tamborini, Arrotex's Chief Innovation Officer and Head of Government Affairs, called the listing an important step ...

Generic and biosimilar maker Sandoz heads 'Great Place To Work' Australia's first list of the best workplaces in biotechnology and pharmaceuticals for 2026.

Prices paid for medicines in Australia, Japan, the United Kingdom and 16 other countries will now help set what US-based companies owe a major US government prescription medicine program.

In this publication's 14 years, only one organisation has answered a question with a response that its internal documents showed to be a deliberate decision to mislead. It was the Therapeutic Goods ...

Melbourne cryopreservation company Vitrafy Life Sciences has signed its third partnership with a US civilian blood network.